| 1.1.1 Age (Classes) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | 1.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 2.1.1 Type of diabetes |
| 2.1.2 Duration of diabetes (Classes) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type of diabetes | 2.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Diabetes Duration | 2.1.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 2.2.1.1 Weight (most recent measurement in 12 mts) |
| 2.2.1.2 BMI |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weight | 2.2.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| BMI | 2.2.1.2 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 2.2.2.1 Smoking status |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smoke | 2.2.2.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 2.2.3.1 Systolic BP (most recent measurement in 12 mts) |
| 2.2.3.2 Diastolic BP (most recent measurement in 12 mts) |
| 2.2.3.3 Total cholesterol |
| 2.2.3.4 HDL-cholesterol |
| 2.2.3.5 Creatinine |
| 2.2.3.6 HbA1c |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBP | 2.2.3.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
| DBP | 2.2.3.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
| Cholesterol | 2.2.3.3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
| HDL | 2.2.3.4 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
| Creatinine | 2.2.3.5 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
| HbA1c | 2.2.3.6 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 2.3.1 Retinopathy |
| 2.3.2 End stage renal failure |
| 2.3.3 Foot ulcer |
| 2.3.4 Lower extremity amputation |
| 2.3.5 Stroke |
| 2.3.6 Myocardial infarction |
| 2.3.7 Hypertension |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retinopathy | 2.3.1 | X | X | X | X | X | X | X | X | X | ||||||||||
| ESRF | 2.3.2 | X | X | X | X | X | X | X | X | X | X | X | ||||||||
| Foot Ulcer | 2.3.3 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Amputation | 2.3.4 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Stroke | 2.3.5 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Miocardial Infarction | 2.3.6 | X | X | X | X | X | X | X | X | X | X | X | ||||||||
| Hypertension | 2.3.7 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 3.1.1 Type of provider |
| 3.1.2 Average diabetes population per centre |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type of Provider | 3.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Age | 3.1.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 3.2.1 Hospital beds per 100,000 |
| 3.2.2 Physicians employed per 100,000 |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital beds | 3.2.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Physicians | 3.2.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 3.3.1.1 Foot Exam: Done |
| 3.3.2.1 Eye Exam: Done |
| 3.3.3.1 BP (1+ measurements in 12 mts) |
| 3.3.3.2 Lipids (1+ measurements in 12 mts) |
| 3.3.3.3 Microalbuminuria (1+ measurements in 12 mts) |
| 3.3.3.4 HbA1c (1+ measurements in 12 mts) |
| 3.3.4.1 Antihypertensive Medication (1+ in 12 mts) |
| 3.3.4.2 Lipid Lowering Treatment (1+ in 12 mts) |
| 3.3.4.3 Antiplatelet therapy (1+ in 12 mts) |
| 3.3.4.4.1 Glucose Lowering: Diet Only |
| 3.3.4.4.2 Glucose Lowering: Tablets Only |
| 3.3.4.4.3 Glucose Lowering: Insulin Only |
| 3.3.4.4.4 Glucose Lowering: Insulin and Tablets |
| 3.3.4.4.5 Glucose Lowering: Insulin Pump |
| 3.3.5.1 Self Monitoring |
| 3.3.5.2 Number of visits on record |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foot Exam: Done | 3.3.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Eye Exam: Done | 3.3.2.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
| BP done | 3.3.3.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
| Lipids | 3.3.3.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
| MA test | 3.3.3.3 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| HbA1c done | 3.3.3.4 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Antihypertensive Medication | 3.3.4.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Lipid Lowering | 3.3.4.2 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Antiplatelet therapy | 3.3.4.3 | X | X | X | X | X | X | X | X | X | ||||||||||
| Diet only | 3.3.4.4.1 | X | X | X | X | X | X | X | X | X | X | |||||||||
| Tablets Only | 3.3.4.4.2 | X | X | X | X | X | X | X | X | X | X | |||||||||
| Insulin Only | 3.3.4.4.3 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Instab | 3.3.4.4.4 | X | X | X | X | X | X | X | X | X | X | X | ||||||||
| Pump Therapy | 3.3.4.4.5 | X | X | X | X | X | X | X | X | X | X | |||||||||
| Self Monitoring | 3.3.5.1 | X | X | X | X | X | X | X | X | |||||||||||
| Number of Visits | 3.3.5.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 4.1.1 Total population |
| 4.1.2 Life expectancy |
| 4.1.3 Mortality |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tot.Pop. | 4.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| Life exp. | 4.1.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Mortality | 4.1.3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 5.1.1 Prevalence of diabetes mellitus per 1,000 |
| 5.1.2 Age at diagnosis by 10 year age bands |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevalence | 5.1.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| Epidemiology | 5.1.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| 5.2.1 Percentage of Adults w 1+ HbA1c tests in 12 mts |
| 5.2.2 Percentage of adults w 1+ microalbumin tests in 12 mts |
| 5.2.3 Percentage of adults w 1+ eye exam in 12 mts |
| 5.2.4 Percentage of adults w 1+ foot exam in 12 mts |
| 5.2.5 Percentage of adults w smoke recorded in 12 mts |
| 5.2.6 Percentage of adults w creatinine tested in 12 mts |
| 5.2.7 Percentage of adults w 1+ BP measurements in 12 mts |
| 5.2.8 Percentage of adults w hypertension+antihyp. medication |
| 5.2.9.1 Oral therapy in adults w diabetes: Sulphonylureas |
| 5.2.9.2 Oral therapy in adults w diabetes: Biguanides |
| 5.2.9.3 Oral therapy in adults w diabetes: Glucoxidase |
| 5.2.9.4 Oral therapy in adults w diabetes: Glitazones |
| 5.2.9.5 Oral therapy in adults w diabetes: Glinides |
| 5.2.10 Percentage of adult subjects treated with insulin |
| 5.2.11 Percentage of adults w diabetes treated w insulin+OADs |
| 5.2.12 Percentage of adults w Pump Therapy |
| 5.2.13 Percentage of adults w antihypertensive treatment |
| 5.2.14 Percentage of adults w lipid lowering treatment |
| 5.2.15 Percentage of adults w antiplatelet therapy |
| 5.2.16 Percentage of adults selfmonitoring blood glucose/urine test |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HbA1c done | 5.2.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| Microalbumin done | 5.2.2 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Eye examination | 5.2.3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
| Foot examination | 5.2.4 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Smoking status | 5.2.5 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Creatinine | 5.2.6 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
| BP measurements | 5.2.7 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
| Hypertension | 5.2.8 | X | X | X | X | X | X | X | X | X | ||||||||||
| Sulphonylureas | 5.2.9.1 | X | X | X | X | X | X | X | X | X | ||||||||||
| Glucoxidase | 5.2.9.2 | X | X | X | X | X | X | X | X | X | ||||||||||
| Glucoxidase | 5.2.9.3 | X | X | X | X | X | X | X | ||||||||||||
| Glitazones | 5.2.9.4 | X | X | X | X | X | X | |||||||||||||
| Glinides | 5.2.9.5 | X | X | X | X | X | ||||||||||||||
| Insulin | 5.2.10 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Insulin+OADs | 5.2.11 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Pump therapy | 5.2.12 | X | X | X | X | X | X | X | X | X | X | |||||||||
| Antihypertensive | 5.2.13 | X | X | X | X | X | X | X | X | X | X | |||||||||
| Lipid lowering treatment | 5.2.14 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Antiplatelet therapy | 5.2.15 | X | X | X | X | X | X | X | X | X | ||||||||||
| Self monitoring | 5.2.16 | X | X | X | X | X | X | X | X |
| c("5.3.1 Percentage of adults w most recent HbA1c", "9.0 pct") |
| c("5.3.2 Percentage of adults w most recent HbA1c", "7.5 pct") |
| c("5.3.3 Percentage of adults w most recent BP", "140/90 mmHg") |
| c("5.3.4 Percentage of adults w most recent BMI", "30") |
| 5.3.5 Percentage of adults w normal microalb. in 12 mts (among tested) |
| 5.3.6 Rate of current smokers among adults |
| 5.3.7 Rate of foot ulceration in adults |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HbA1c | 5.3.1 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| HbA1c | 5.3.2 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| BP | 5.3.3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
| BMI | 5.3.4 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Microalbuminuria | 5.3.5 | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Current Smokers | 5.3.6 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||
| Foot Ulceration | 5.3.7 | X | X | X | X | X | X | X | X | X | X | X | X |
| 5.4.1 Annual incidence of dialysis and/or transplant among adults |
| 5.4.2 End stage renal failure in adults |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis | 5.4.1 | X | X | X | X | |||||||||||||||
| ESRF | 5.4.2 | X | X | X | X | X | X | X | X | X | X |
| 6.1.1 Age (Classes) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | 6.1.1 | X | X | X | X | X | X | X | X | X | X | X |
| 6.2.1 Type of Diabetes |
| 6.2.2 Duration of diabetes (Classes) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type | 6.2.1 | X | X | X | X | X | X | X | X | X | X | X | ||||||||
| Duration of Diabetes | 6.2.2 | X | X | X | X | X | X | X | X | X | X | X |
| 6.3.1 Height (most recent measurement in 12 mts) |
| 6.3.2 BMI (most recent measurement in 12 mts) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Height | 6.3.1 | X | X | X | X | X | X | X | X | X | X | |||||||||
| BMI | 6.3.2 | X | X | X | X | X | X | X | X |
| 6.4.1 HbA1c (most recent measurement in 12 mts) |
| Indicator | Code | 01 | 02 | 03 | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HbA1c | 6.4.1 | X | X | X | X | X | X | X | X | X | X | X |